share_log

Canaccord Genuity Maintains Buy on Quipt Home Medical, Lowers Price Target to $8

Canaccord Genuity Maintains Buy on Quipt Home Medical, Lowers Price Target to $8

Canaccord Genuity 維持對Quipt Home Medical的買入,將目標股價下調至8美元
Benzinga ·  05/17 22:43

Canaccord Genuity analyst Richard Close maintains Quipt Home Medical (NASDAQ:QIPT) with a Buy and lowers the price target from $9 to $8.

Canaccord Genuity分析師理查德·克洛斯維持Quipt Home Medical(納斯達克股票代碼:QIPT)的買入並將目標股價從9美元下調至8美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論